Research groups
Collaborators
-
Carl Heneghan
Professor of Evidence-Based Medicine
-
Chris Butler
Professor of Primary Care
-
Anne-Marie Boylan
Departmental Lecturer & Senior Researcher
-
Sarah Tonkin-Crine
Associate Professor & Health Psychologist
Research groups
Colleges
Kome Gbinigie
MA(Cantab), MB BChir, MRCGP, DRCOG, DfSRH, PGCert(Health Research), DPhil(Oxon)
Post-doctoral researcher
- Clinical trials and infectious diseases researcher
- GP
- Community cardiologist
In Memoriam
Kome was a post-doctoral researcher, a GP at a practice in Oxford and also worked as a community cardiologist. During her NIHR-funded academic clinical fellowship (ACF), she developed a keen interest in improving the diagnosis and management of common infections. Her Wellcome Trust-funded DPhil focused on non-antibiotic treatment of common bacterial infections, namely, the use of cranberry extract as a means of managing acute urinary tract infections. At a post-doctoral level, in addition to pursuing antibiotic stewardship research,she worked on national (PRINCIPLE and PANORAMIC) and international (ECRAID-Prime) platform therapeutic clinical trials for epidemic and pandemic illnesses.
Kome passed away after a short illness on 28 January 2024. Dr Oghenekome Gbinigie (Kome) – a tribute — Nuffield Department of Primary Care Health Sciences, University of Oxford
Recent publications
-
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.
Journal article
Png ME. et al, (2024), Br J Gen Pract
-
Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Journal article
Gbinigie O. et al, (2023), BMJ Open, 13
-
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Journal article
Butler CC. et al, (2023), The Lancet, 401, 281 - 293
-
Enhancing opportunistic recruitment and retention in primary care trials: lessons learned from a qualitative study embedded in the Cranberry for Urinary Tract Infection (CUTI) feasibility trial
Journal article
Gbinigie OA. et al, (2022), BMC Primary Care, 23
-
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Journal article
Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455